LifeSharers Members Agree to Donate to One Another First

HealthDay - FRIDAY, Sept. 29 (HealthDay News) -- Patients taking an investigational weight-loss drug called Contrave lost an average of more than 7 percent of their weight in the first 24 weeks of a phase III clinical trial, according to interim findings ...

Genetic mutation doubles breast cancer risk -study Reuters.uk - WASHINGTON (Reuters) - British researchers said they had found a new genetic mutation that doubled the risk of breast cancer in women who carry it.